Torthaí cuardaigh - B Charpentier

  • 1 - 11 toradh as 11 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Impact of Early or Delayed Cyclosporine on Delayed Graft Function in Renal Transplant Recipients: A Randomized, Multicenter Study

    Impact of Early or Delayed Cyclosporine on Delayed Graft Function in Renal Transplant Recipients: A Randomized, Multicenter Study de réir Nassim Kamar, Valérie Garrigue, A. Karras, G. Mourad, N Lefrançois, B Charpentier, Christophe Legendre, Lionel Rostaing

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    BENEFIT-RISK PROFILE OF THE BELATACEPT LI REGIMEN AT 2 YEARS IN EBV(+) KIDNEY TRANSPLANT RECIPIENTS

    BENEFIT-RISK PROFILE OF THE BELATACEPT LI REGIMEN AT 2 YEARS IN EBV(+) KIDNEY TRANSPLANT RECIPIENTS de réir F. Vincenti, J. Grinyó, Christian P. Larsen, José Osmar Medina Pestana, Yves Vanrenterghem, Tao Duan, Mamta Agarwal, B Charpentier

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    OUTCOMES AS A FUNCTION OF DONOR:RECIPIENT CHARACTERISTICS FROM A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT)

    OUTCOMES AS A FUNCTION OF DONOR:RECIPIENT CHARACTERISTICS FROM A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT) de réir F. Vincenti, Josep M. Grinyó, B Charpentier, José Osmar Medina Pestana, Lionel Rostaing, Yves Vanrenterghem, Chih‐Chung Lin, G. Russo, Christian P. Larsen

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR OUTCOMES FROM THE BENEFIT STUDY

    BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR OUTCOMES FROM THE BENEFIT STUDY de réir Christian P. Larsen, Josep M. Grinyó, B Charpentier, José Osmar Medina Pestana, Nassim Kamar, Yves Vanrenterghem, Chih‐Chung Lin, G. Russo, Pushkal Garg, F. Vincenti

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia

    FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia de réir Maurizio Salvadori, Klemens Budde, B Charpentier, Jürgen Klempnauer, Björn Nashan, Luis Pallardó, Josette Eris, Francesco Paolo Schena, Ute Eisenberger, Lionel Rostaing, Abdel Hmissi, Shreeram Aradhye

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose—response study in elderly nursing-home residents and young volunteers

    Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose—response study in elderly nursing-home residents a... de réir A.M. Palache, W.E.P. Beyer, M Sprenger, N. Masurel, S. De Jonge, A. Vardy, B Charpentier, J. Noury, W.C.A. van Beek, Rowie Borst, Gerard J. Ligthart, G. Keren, Eitan Rubinstein

    Foilsithe / Cruthaithe 1993
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials

    Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials de réir Bernhard K. Krämer, Luisa Albano, Bernhard Banas, B Charpentier, Lars Bäckman, Hélio Tedesco‐Silva, Frank Lehner, G. Mondragon-Ramirez, Maciej Głyda, E. Cassuto‐Viguier, Ondřej Viklický, G. Mourad, Paolo Rigotti, S Schleibner, Nassim Kamar

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study

    Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study de réir Rachel Hellemans, Marc Hazzan, D. Durand, G. Mourad, P Lang, Martin Kessler, B Charpentier, Guy Touchard, F. Berthoux, Pierre Merville, Nacéra Ouali, J.P. Squifflet, François Bayle, Karl Martin Wissing, C. Noël, Daniel Abramowicz

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients

    Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients de réir Flavio Vincenti, Christian P. Larsen, Josefina Alberú, Barbara A. Bresnahan, Valter Duro Garcı́a, J. Kothari, Philippe Lang, Eduardo Mancilla Urrea, P. Massari, G. Mondragon-Ramirez, Rafael Reyes‐Acevedo, Kim Rice, Lionel Rostaing, S. Steinberg, J. Xing, Mamta Agarwal, M. Harler, B Charpentier

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study

    Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Rand... de réir Philippe Gatault, Nassim Kamar, M. Büchler, Claudio Colosio, Dominique Bertrand, Antoine Dürrbach, Laetitia Albano, J Rivalan, Yannick Le Meur, Marie Essig, Nicolas Bouvier, Christophe Legendre, Bruno Moulin, A.E. Heng, P.-F. Weestel, Johnny Sayegh, B Charpentier, Lionel Rostaing, Éric Thervet, Yvon Lebranchu

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice

    Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice de réir Paula M. Chilton, Smita Ghare, B Charpentier, S Myers, Aakarsha V. Rao, Joseph F. Petrosino, Kristi L. Hoffman, John C. Greenwell, Neetu Tyagi, Jyotirmaya Behera, Yali Wang, Lucy Sloan, JingWen Zhang, Christopher Shields, Gregory E. Cooper, Leila Gobejishvili, Scott R. Whittemore, Craig J. McClain, Shirish Barve

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: